Comanche Biopharma

Aggamin

This biotechnology company develops an extracorporeal device to treat preeclampsia by reducing circulating pathogenic proteins for pregnant women and healthcare providers.

Argonaute RNA

This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.

Prophylix Pharma

This company develops antibody therapies to treat fetal and neonatal alloimmune thrombocytopenia in unborn babies and newborns.

Coagulant Therapeutics

This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.

NX Prenatal

This company develops exosome-based blood tests to detect pregnancy complications for physicians and expectant mothers.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

Dicerna Pharmaceuticals

This biopharmaceutical company develops ribonucleic acid interference therapeutics to treat rare, chronic, and infectious diseases for healthcare providers and global pharmaceutical partners.

Prophylix Pharma AS

The company develops antibody-based prophylactic treatments for fetal and neonatal alloimmune thrombocytopenia to prevent life-threatening bleeding and brain injury in newborns.